Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Eugene Corp. (023410:KRX), powered by AI.
Eugene Corp. is currently trading at ₩3,540. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Eugene Corp. on Alpha Lenz.
Eugene Corp.'s P/E ratio is -26.7.
“Eugene Corp. trades at a P/E of -26.7 (undervalued) with modest ROE of -1.2%.”
Ask for details →Eugene Corp. is a distinguished entity in the South Korean chemical industry, specializing in the production and distribution of chemical products that cater to a wide array of industrial applications. The corporation's primary function is to deliver essential chemical materials and solutions that serve as foundational elements in manufacturing processes for various sectors. These sectors include electronics, automotive, construction, and consumer goods industries, highlighting the company's significant impact and integral role. Eugene Corp.'s product offerings include advanced materials such as polymers, resins, and solvents, designed to meet the diverse and evolving needs of its industrial clientele. The corporation’s capacity to innovate and adapt to technological advancements positions it as a crucial player in the market, often setting trends with its cutting-edge chemical solutions. Market significance is underscored by Eugene Corp.'s commitment to sustainability and efficient resource management, addressing both environmental impact and economic performance. As such, the company is a pivotal contributor to enhancing industrial efficiencies and sustainability, thereby reinforcing its role as a leader in the regional and global chemical markets.
“Eugene Corp. trades at a P/E of -26.7 (undervalued) with modest ROE of -1.2%.”
Ask for details →Eugene Corp. (ticker: 023410) is a company listed on KRX in the Financial Services sector (Capital Markets). It has approximately 621 employees. Market cap is $273.7B.
The current price is ₩3,540 with a P/E ratio of -26.73x and P/B of 0.31x.
ROE is -1.16% and operating margin is 2.43%. Annual revenue is $1.3T.